Malek N - Search Results

1

Commentary: "Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis".

Lawton M, Ben-Shlomo Y, Athauda D, Malek N, Grosset DG. Lawton M, et al. Among authors: malek n. Front Aging Neurosci. 2023 Jun 15;15:1223636. doi: 10.3389/fnagi.2023.1223636. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37396660 Free PMC article. No abstract available.

2

Phase IIa randomized double-blind, placebo-controlled study of inhaled apomorphine as acute challenge for rescuing 'off' periods in patients with established Parkinson's disease.

Grosset KA, Malek N, Morgan F, Grosset DG. Grosset KA, et al. Among authors: malek n. Eur J Neurol. 2013 Nov;20(11):1445-50. doi: 10.1111/ene.12091. Epub 2013 Jan 28. Eur J Neurol. 2013. PMID: 23350812 Clinical Trial.

3

Prescription of drugs with potential adverse effects on cardiac conduction in Parkinson's disease.

Malek NM, Grosset KA, Stewart D, Macphee GJ, Grosset DG. Malek NM, et al. Parkinsonism Relat Disord. 2013 Jun;19(6):586-9. doi: 10.1016/j.parkreldis.2013.02.004. Epub 2013 Mar 20. Parkinsonism Relat Disord. 2013. PMID: 23522959

4

Inhaled dry powder apomorphine (VR040) for 'off ' periods in Parkinson's disease: an in-clinic double-blind dose ranging study.

Grosset KA, Malek N, Morgan F, Grosset DG. Grosset KA, et al. Among authors: malek n. Acta Neurol Scand. 2013 Sep;128(3):166-71. doi: 10.1111/ane.12107. Epub 2013 Mar 26. Acta Neurol Scand. 2013. PMID: 23527823 Clinical Trial.

5

Inhaled apomorphine in patients with 'on-off' fluctuations: a randomized, double-blind, placebo-controlled, clinic and home based, parallel-group study.

Grosset KA, Malek N, Morgan F, Grosset DG. Grosset KA, et al. Among authors: malek n. J Parkinsons Dis. 2013;3(1):31-7. doi: 10.3233/JPD-120142. J Parkinsons Dis. 2013. PMID: 23938309 Clinical Trial.

6

Baseline [(123) I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease.

Nissen T, Malek N, Grosset KA, Newman EJ, Patterson J, Hadley D, Grosset DG. Nissen T, et al. Among authors: malek n. Acta Neurol Scand. 2014 Mar;129(3):204-8. doi: 10.1111/ane.12178. Epub 2013 Aug 20. Acta Neurol Scand. 2014. PMID: 23962145

7

Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.

Malek N, Swallow D, Grosset KA, Anichtchik O, Spillantini M, Grosset DG. Malek N, et al. Acta Neurol Scand. 2014 Aug;130(2):59-72. doi: 10.1111/ane.12247. Epub 2014 Apr 5. Acta Neurol Scand. 2014. PMID: 24702516 Review.

8

Medication adherence in patients with Parkinson's disease.

Malek N, Grosset DG. Malek N, et al. CNS Drugs. 2015 Jan;29(1):47-53. doi: 10.1007/s40263-014-0220-0. CNS Drugs. 2015. PMID: 25503824 Review.

9

Tracking Parkinson's: Study Design and Baseline Patient Data.

Malek N, Swallow DM, Grosset KA, Lawton MA, Marrinan SL, Lehn AC, Bresner C, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG; PRoBaND. Malek N, et al. J Parkinsons Dis. 2015;5(4):947-59. doi: 10.3233/JPD-150662. J Parkinsons Dis. 2015. PMID: 26485428 Free PMC article.

10

Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.

Malek N, Swallow DM, Grosset KA, Lawton MA, Smith CR, Bajaj NP, Barker RA, Ben-Shlomo Y, Bresner C, Burn DJ, Foltynie T, Morris HR, Williams N, Wood NW, Grosset DG; PRoBaND Investigators. Malek N, et al. Acta Neurol Scand. 2016 Oct;134(4):271-6. doi: 10.1111/ane.12538. Epub 2015 Dec 1. Acta Neurol Scand. 2016. PMID: 26626018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters